San Francisco, CA, United States of America

Donna A A W Hayes

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):

Title: The Innovations of Donna A A W Hayes

Introduction

Donna A A W Hayes is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of plasma kallikrein inhibitors. His work focuses on creating compounds that can effectively treat various disease states.

Latest Patents

Hayes holds a patent for his invention titled "Plasma kallikrein inhibitors." This patent provides a compound of Formula (I) and pharmaceutical compositions that include one or more of these compounds. The methods outlined in the patent are aimed at treating or preventing conditions such as hereditary angioedema, uveitis, posterior uveitis, wet age-related macular edema, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion. The compounds developed by Hayes are selective inhibitors of plasma kallikrein, showcasing his innovative approach to addressing complex medical issues. He has 1 patent to his name.

Career Highlights

Hayes is currently associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His role there allows him to leverage his expertise in drug development and contribute to groundbreaking research in the field. His work has the potential to impact many patients suffering from debilitating conditions.

Collaborations

Hayes collaborates with various professionals in the industry, including his coworker Salman Jabri. Their combined efforts aim to advance the understanding and treatment of diseases related to plasma kallikrein.

Conclusion

Donna A A W Hayes is a notable inventor whose work in plasma kallikrein inhibitors represents a significant advancement in pharmaceutical innovation. His contributions have the potential to improve the lives of many individuals affected by serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…